Pharmaceutical Glycerine Market By Application (Excipient, Glycerin As Care Product): Global Opportunity Analysis and Industry Forecast, 2020-2030

Pharmaceutical Glycerine Market

The total volume of global pharmaceutical glycerin market was 132,000 tons in 2020, and is projected to reach 243,641 tons by 2030, registering a CAGR of 6.6% from 2021 to 2030.

Glycerol is a colorless syrupy liquid that is used medically as a laxative, given orally as an enema, or in the form of suppositories. Glycerol has multiple uses in food, chemical, pharmaceutical, and biotechnological industries as a sweetener, a humectant, a solvent, or as feeding stock for microbial cultures.

The pharmaceutical glycerin market is witnessing tremendous growth, owing to antimicrobial and antiviral properties. It is widely used in pharmaceutical preparations as a means of improving smoothness, providing lubrication, and treating skin damage. It also finds its application in allergen immunotherapies, cough syrups, elixirs and expectorants, glycerin soaps, and water-based personal lubricants. Nitro-glycerin is one of the most common treatments for treating chronic angina, chest pain, and heart disease. The medication of Glycerin is used as a moisturizer to treat or prevent dry, rough, scaly, itchy skin and minor skin irritations in the healthcare industry. Growth in demand for glycerin in the pharmaceutical industry. Glycerin is used as a humectant and emollient in skincare, hair care, oral care, and cosmetics among others to enhance physical texture, inducing keratinocyte proliferation, healing wounds, and reducing melanin intensity. In addition, growing skincare and beauty & personal care industry, coupled with aging population and increasing self-consciousness are some of the additional factors anticipated to contribute toward the market growth. Apart from this, high demand for glycerin in the personal care and cosmetics industry is also estimated to accelerate growth of the market during the forecast period. Glycerin is used widely in hand sanitizers and in oral healthcare products. Owing to the COVID-19 pandemic, demand for hand sanitizers witnessed a massive surge, thereby leading to rise in need among manufacturers of hand sanitizers to source glycerin in high quantities. On the other hand, increase in oral health diseases globally, which according to the statistics by the World Health Organization (WHO) is recorded to affect 3.5 Billion people, is also anticipated to propel the market growth.

Rise in inclination of consumers toward natural personal care and cosmetics products is set to propel the glycerin market growth in the coming years. This mainly occurs, owing to increasing awareness programs among masses regarding harmful effects of chemical ingredients.

The pharmaceutical glycerin market in this report is studied on the basis of application and region. On the basis of application, the market is divided as excipient and glycerin as a care product. Excipients are further divided into fillers & plasticizer, solubilizer & emulsifier, solvent, diluent & base, lubricant, thickener, and sweetener. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Region wise, Asia-Pacific dominated the market in 2020, and is expected to maintain it in the forecast period, owing to the high presence of top glycerin-producing countries such as Malaysia, Indonesia, India, and Japan has resulted in a competitive environment in terms of production technologies and securing production capacities in the region. Also, on account of the favorable growth of end-use industries in China, India, and South East Asia, the region is expected to register the fastest growth during the foreseeable period.

The major players operating in the Global Pharmaceutical Glycerin market are Archer Daniels Midland Company, Cargill Inc., DuPont de Nemours, Inc., Emery Oleo chemicals Group, Godrej Group, Procter and Gamble Co., Reagents, Renewable Energy Group Inc., The Chemical Company, and Universal Preserv-A-Chem, Inc. These players adopted product launch, collaboration, and merger & acquisition as their key developmental strategies.

KEY BENEFITS FOR STAKEHOLDERS

The report provides in-depth analysis of the Global Pharmaceutical Glycerin market size along with the current trends and future estimations to elucidate the imminent investment pockets.

It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.

A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.

The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the Global Pharmaceutical Glycerin market growth.

[S1]Update from amr rd and consider it fina

Scope of Pharmaceutical Glycerine Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 Excipient

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.3 Glycerin As Care Product

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 North America

5.2.1 Key trends and opportunities

5.2.2 North America Market size and forecast, by Application

5.2.3 North America Market size and forecast, by country

5.2.3.1 U.S.

5.2.3.1.1 Market size and forecast, by Application

5.2.3.2 Canada

5.2.3.2.1 Market size and forecast, by Application

5.2.3.3 Mexico

5.2.3.3.1 Market size and forecast, by Application

5.3 Europe

5.3.1 Key trends and opportunities

5.3.2 Europe Market size and forecast, by Application

5.3.3 Europe Market size and forecast, by country

5.3.3.1 Germany

5.3.3.1.1 Market size and forecast, by Application

5.3.3.2 France

5.3.3.2.1 Market size and forecast, by Application

5.3.3.3 United Kingdom

5.3.3.3.1 Market size and forecast, by Application

5.3.3.4 Italy

5.3.3.4.1 Market size and forecast, by Application

5.3.3.5 Spain

5.3.3.5.1 Market size and forecast, by Application

5.3.3.6 Rest of Europe

5.3.3.6.1 Market size and forecast, by Application

5.4 Asia-Pacific

5.4.1 Key trends and opportunities

5.4.2 Asia-Pacific Market size and forecast, by Application

5.4.3 Asia-Pacific Market size and forecast, by country

5.4.3.1 Japan

5.4.3.1.1 Market size and forecast, by Application

5.4.3.2 China

5.4.3.2.1 Market size and forecast, by Application

5.4.3.3 Australia

5.4.3.3.1 Market size and forecast, by Application

5.4.3.4 India

5.4.3.4.1 Market size and forecast, by Application

5.4.3.5 South Korea

5.4.3.5.1 Market size and forecast, by Application

5.4.3.6 Rest of Asia-Pacific

5.4.3.6.1 Market size and forecast, by Application

5.5 LAMEA

5.5.1 Key trends and opportunities

5.5.2 LAMEA Market size and forecast, by Application

5.5.3 LAMEA Market size and forecast, by country

5.5.3.1 Brazil

5.5.3.1.1 Market size and forecast, by Application

5.5.3.2 Saudi Arabia

5.5.3.2.1 Market size and forecast, by Application

5.5.3.3 South Africa

5.5.3.3.1 Market size and forecast, by Application

5.5.3.4 Rest of LAMEA

5.5.3.4.1 Market size and forecast, by Application

6.1. Introduction

6.2. Top winning strategies

6.3. Product Mapping of Top 10 Player

6.4. Competitive Dashboard

6.5. Competitive Heatmap

6.6. Key developments

7.1 DuPont

7.1.1 Company overview

7.1.2 Company snapshot

7.1.3 Operating business segments

7.1.4 Product portfolio

7.1.5 Business performance

7.1.6 Key strategic moves and developments

7.2 cargill

7.2.1 Company overview

7.2.2 Company snapshot

7.2.3 Operating business segments

7.2.4 Product portfolio

7.2.5 Business performance

7.2.6 Key strategic moves and developments

7.3 Universal Preserv A Chem Inc.

7.3.1 Company overview

7.3.2 Company snapshot

7.3.3 Operating business segments

7.3.4 Product portfolio

7.3.5 Business performance

7.3.6 Key strategic moves and developments

7.4 TCC Glycerin

7.4.1 Company overview

7.4.2 Company snapshot

7.4.3 Operating business segments

7.4.4 Product portfolio

7.4.5 Business performance

7.4.6 Key strategic moves and developments

7.5 Procter and Gamble Co

7.5.1 Company overview

7.5.2 Company snapshot

7.5.3 Operating business segments

7.5.4 Product portfolio

7.5.5 Business performance

7.5.6 Key strategic moves and developments

7.6 Godrej Group

7.6.1 Company overview

7.6.2 Company snapshot

7.6.3 Operating business segments

7.6.4 Product portfolio

7.6.5 Business performance

7.6.6 Key strategic moves and developments

7.7 Emery Oleochemicals Group

7.7.1 Company overview

7.7.2 Company snapshot

7.7.3 Operating business segments

7.7.4 Product portfolio

7.7.5 Business performance

7.7.6 Key strategic moves and developments

7.8 Archer Daniels Midland Company

7.8.1 Company overview

7.8.2 Company snapshot

7.8.3 Operating business segments

7.8.4 Product portfolio

7.8.5 Business performance

7.8.6 Key strategic moves and developments

7.9 Renewable Energy Group, Inc.

7.9.1 Company overview

7.9.2 Company snapshot

7.9.3 Operating business segments

7.9.4 Product portfolio

7.9.5 Business performance

7.9.6 Key strategic moves and developments

7.10 Reagents Company

7.10.1 Company overview

7.10.2 Company snapshot

7.10.3 Operating business segments

7.10.4 Product portfolio

7.10.5 Business performance

7.10.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION)

TABLE 2. PHARMACEUTICAL GLYCERINE MARKET REVENUE, FOR EXCIPIENT, BY REGION , 2020-2030,($MILLION)

TABLE 3. PHARMACEUTICAL GLYCERINE MARKET EXCIPIENT BY COUNTRY, 2020-2030,($MILLION)

TABLE 4. PHARMACEUTICAL GLYCERINE MARKET REVENUE, FOR GLYCERIN AS CARE PRODUCT, BY REGION , 2020-2030,($MILLION)

TABLE 5. PHARMACEUTICAL GLYCERINE MARKET GLYCERIN AS CARE PRODUCT BY COUNTRY, 2020-2030,($MILLION)

TABLE 6. PHARMACEUTICAL GLYCERINE MARKET, BY REGION, 2020-2030,($MILLION)

TABLE 7. NORTH AMERICA PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION)

TABLE 8. NORTH AMERICA PHARMACEUTICAL GLYCERINE MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 9. U.S. PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 10. CANADA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 11. MEXICO PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 12. EUROPE PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION)

TABLE 13. EUROPE PHARMACEUTICAL GLYCERINE MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 14. GERMANY PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 15. FRANCE PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 16. UNITED KINGDOM PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 17. ITALY PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 18. SPAIN PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 19. REST OF EUROPE PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 20. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION)

TABLE 21. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 22. JAPAN PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 23. CHINA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 24. AUSTRALIA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 25. INDIA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 26. SOUTH KOREA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 27. REST OF ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 28. LAMEA PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION)

TABLE 29. LAMEA PHARMACEUTICAL GLYCERINE MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 30. BRAZIL PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 31. SAUDI ARABIA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 32. SOUTH AFRICA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 33. REST OF LAMEA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 34.DUPONT: COMPANY SNAPSHOT

TABLE 35.DUPONT: OPERATING SEGMENTS

TABLE 36.DUPONT: PRODUCT PORTFOLIO

TABLE 37.DUPONT: NET SALES,

TABLE 38.DUPONT: KEY STRATERGIES

TABLE 39.CARGILL: COMPANY SNAPSHOT

TABLE 40.CARGILL: OPERATING SEGMENTS

TABLE 41.CARGILL: PRODUCT PORTFOLIO

TABLE 42.CARGILL: NET SALES,

TABLE 43.CARGILL: KEY STRATERGIES

TABLE 44.UNIVERSAL PRESERV A CHEM INC.: COMPANY SNAPSHOT

TABLE 45.UNIVERSAL PRESERV A CHEM INC.: OPERATING SEGMENTS

TABLE 46.UNIVERSAL PRESERV A CHEM INC.: PRODUCT PORTFOLIO

TABLE 47.UNIVERSAL PRESERV A CHEM INC.: NET SALES,

TABLE 48.UNIVERSAL PRESERV A CHEM INC.: KEY STRATERGIES

TABLE 49.TCC GLYCERIN: COMPANY SNAPSHOT

TABLE 50.TCC GLYCERIN: OPERATING SEGMENTS

TABLE 51.TCC GLYCERIN: PRODUCT PORTFOLIO

TABLE 52.TCC GLYCERIN: NET SALES,

TABLE 53.TCC GLYCERIN: KEY STRATERGIES

TABLE 54.PROCTER AND GAMBLE CO: COMPANY SNAPSHOT

TABLE 55.PROCTER AND GAMBLE CO: OPERATING SEGMENTS

TABLE 56.PROCTER AND GAMBLE CO: PRODUCT PORTFOLIO

TABLE 57.PROCTER AND GAMBLE CO: NET SALES,

TABLE 58.PROCTER AND GAMBLE CO: KEY STRATERGIES

TABLE 59.GODREJ GROUP: COMPANY SNAPSHOT

TABLE 60.GODREJ GROUP: OPERATING SEGMENTS

TABLE 61.GODREJ GROUP: PRODUCT PORTFOLIO

TABLE 62.GODREJ GROUP: NET SALES,

TABLE 63.GODREJ GROUP: KEY STRATERGIES

TABLE 64.EMERY OLEOCHEMICALS GROUP: COMPANY SNAPSHOT

TABLE 65.EMERY OLEOCHEMICALS GROUP: OPERATING SEGMENTS

TABLE 66.EMERY OLEOCHEMICALS GROUP: PRODUCT PORTFOLIO

TABLE 67.EMERY OLEOCHEMICALS GROUP: NET SALES,

TABLE 68.EMERY OLEOCHEMICALS GROUP: KEY STRATERGIES

TABLE 69.ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT

TABLE 70.ARCHER DANIELS MIDLAND COMPANY: OPERATING SEGMENTS

TABLE 71.ARCHER DANIELS MIDLAND COMPANY: PRODUCT PORTFOLIO

TABLE 72.ARCHER DANIELS MIDLAND COMPANY: NET SALES,

TABLE 73.ARCHER DANIELS MIDLAND COMPANY: KEY STRATERGIES

TABLE 74.RENEWABLE ENERGY GROUP, INC.: COMPANY SNAPSHOT

TABLE 75.RENEWABLE ENERGY GROUP, INC.: OPERATING SEGMENTS

TABLE 76.RENEWABLE ENERGY GROUP, INC.: PRODUCT PORTFOLIO

TABLE 77.RENEWABLE ENERGY GROUP, INC.: NET SALES,

TABLE 78.RENEWABLE ENERGY GROUP, INC.: KEY STRATERGIES

TABLE 79.REAGENTS COMPANY: COMPANY SNAPSHOT

TABLE 80.REAGENTS COMPANY: OPERATING SEGMENTS

TABLE 81.REAGENTS COMPANY: PRODUCT PORTFOLIO

TABLE 82.REAGENTS COMPANY: NET SALES,

TABLE 83.REAGENTS COMPANY: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.PHARMACEUTICAL GLYCERINE MARKET SEGMENTATION

FIGURE 2.PHARMACEUTICAL GLYCERINE MARKET,2020-2030

FIGURE 3.PHARMACEUTICAL GLYCERINE MARKET,2020-2030

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.PHARMACEUTICAL GLYCERINE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 11.PHARMACEUTICAL GLYCERINE MARKET,BY APPLICATION,2020(%)

FIGURE 12.COMPARATIVE SHARE ANALYSIS OF EXCIPIENT PHARMACEUTICAL GLYCERINE MARKET,2020-2030(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF GLYCERIN AS CARE PRODUCT PHARMACEUTICAL GLYCERINE MARKET,2020-2030(%)

FIGURE 14.PHARMACEUTICAL GLYCERINE MARKET BY REGION,2020

FIGURE 15.U.S. PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)

FIGURE 16.CANADA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)

FIGURE 17.MEXICO PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)

FIGURE 18.GERMANY PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)

FIGURE 19.FRANCE PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)

FIGURE 20.UNITED KINGDOM PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)

FIGURE 21.ITALY PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)

FIGURE 22.SPAIN PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)

FIGURE 23.REST OF EUROPE PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)

FIGURE 24.JAPAN PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)

FIGURE 25.CHINA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)

FIGURE 26.AUSTRALIA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)

FIGURE 27.INDIA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)

FIGURE 28.SOUTH KOREA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)

FIGURE 29.REST OF ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)

FIGURE 30.BRAZIL PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)

FIGURE 31.SAUDI ARABIA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)

FIGURE 32.SOUTH AFRICA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)

FIGURE 33.REST OF LAMEA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION)

FIGURE 34. TOP WINNING STRATEGIES, BY YEAR

FIGURE 35. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 36. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 37.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 38.COMPETITIVE DASHBOARD

FIGURE 39.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 40.DUPONT.: NET SALES ,($MILLION)

FIGURE 41.CARGILL.: NET SALES ,($MILLION)

FIGURE 42.UNIVERSAL PRESERV A CHEM INC..: NET SALES ,($MILLION)

FIGURE 43.TCC GLYCERIN.: NET SALES ,($MILLION)

FIGURE 44.PROCTER AND GAMBLE CO.: NET SALES ,($MILLION)

FIGURE 45.GODREJ GROUP.: NET SALES ,($MILLION)

FIGURE 46.EMERY OLEOCHEMICALS GROUP.: NET SALES ,($MILLION)

FIGURE 47.ARCHER DANIELS MIDLAND COMPANY.: NET SALES ,($MILLION)

FIGURE 48.RENEWABLE ENERGY GROUP, INC..: NET SALES ,($MILLION)

FIGURE 49.REAGENTS COMPANY.: NET SALES ,($MILLION